Randomised trials in ovarian cancer: trial design considerations

被引：6
|
作者：
Brady, MF
Thigpen, JT
Vermorken, JB
Parmar, MKB
机构：
[1] Roswell Pk Canc Inst, GOG Stat Off, Buffalo, NY 14263 USA
[2] Univ Mississippi, Sch Med, Dept Med, Jackson, MS 39216 USA
[3] Univ Antwerp Hosp, Dept Med Oncol, Edegem, Belgium
[4] MRC, Canc Trials Off, Cambridge, England
来源：
ANNALS OF ONCOLOGY | 1999年 / 10卷
关键词：
end point selection; progression-free survival; response; survival; trial size;
D O I：
10.1023/A:1008319704310
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Randomised clinical trials are considered the definitive source of evidence for guiding decisions in clinical practice. The concept of a clinical trial is based on sound scientific, ethical, and practical principles. The strength of evidence that an individual trial provides is assessed on the manner in which these principles are incorporated into the design and execution of the trial. Since the way these principles are incorporated into a trial is judgmental, the strength of evidence from an individual trial is a matter of degree. The purpose of this paper is to present some of the scientific, ethical and practical considerations surrounding the selection of endpoints and determination of sample size for trials in ovarian cancer.
引用
收藏
页码：75 / 82
页数：8
相关论文
共 50 条
  • [41] Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer
    Penelope E. Schofield
    M. R. Stockler
    D. Zannino
    N. C. Tebbutt
    T. J. Price
    R. J. Simes
    N. Wong
    N. Pavlakis
    D. Ransom
    E. Moylan
    C. Underhill
    D. Wyld
    I. Burns
    R. Ward
    N. Wilcken
    M. Jefford
    Supportive Care in Cancer, 2016, 24 : 401 - 408
  • [42] Psychosocial group intervention for patients with primary breast cancer: A randomised trial
    Boesen, Ellen H.
    Karlsen, Randi
    Christensen, Jane
    Paaschburg, Birgitte
    Nielsen, Dorte
    Bloch, Iben Seier
    Christiansen, Birgitte
    Jacobsen, Kathrine
    Johansen, Christoffer
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (09) : 1363 - 1372
  • [43] Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer
    Schofield, Penelope E.
    Stockler, M. R.
    Zannino, D.
    Tebbutt, N. C.
    Price, T. J.
    Simes, R. J.
    Wong, N.
    Pavlakis, N.
    Ransom, D.
    Moylan, E.
    Underhill, C.
    Wyld, D.
    Burns, I.
    Ward, R.
    Wilcken, N.
    Jefford, M.
    SUPPORTIVE CARE IN CANCER, 2016, 24 (01) : 401 - 408
  • [44] In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome
    Creemers, Jeroen H. A.
    Ankan, Ankur
    Roes, Kit C. B.
    Schroeder, Gijs
    Mehra, Niven
    Figdor, Carl G.
    de Vries, I. Jolanda M.
    Textor, Johannes
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [45] Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
    Scher, Howard I.
    Morris, Michael J.
    Stadler, Walter M.
    Higano, Celestia
    Basch, Ethan
    Fizazi, Karim
    Antonarakis, Emmanuel S.
    Beer, Tomasz M.
    Carducci, Michael A.
    Chi, Kim N.
    Corn, Paul G.
    de Bono, Johann S.
    Dreicer, Robert
    George, Daniel J.
    Heath, Elisabeth I.
    Hussain, Maha
    Kelly, Wm. Kevin
    Liu, Glenn
    Logothetis, Christopher
    Nanus, David
    Stein, Mark N.
    Rathkopf, Dana E.
    Slovin, Susan F.
    Ryan, Charles J.
    Sartor, Oliver
    Small, Eric J.
    Smith, Matthew Raymond
    Sternberg, Cora N.
    Taplin, Mary-Ellen
    Wilding, George
    Nelson, Peter S.
    Schwartz, Lawrence H.
    Halabi, Susan
    Kantoff, Philip W.
    Armstrong, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (12) : 1402 - +
  • [46] Design and performance of clinical trials in head and neck cancer
    Awada, Ahmad
    Lacombe, Denis
    Liberatoscioli, Cecilia
    CURRENT OPINION IN ONCOLOGY, 2010, 22 (03) : 184 - 185
  • [47] Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer - An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
    Dilley, James
    Gentry-Maharaj, Aleksandra
    Ryan, Andy
    Burnell, Matthew
    Manchanda, Ranjit
    Kalsi, Jatinderpal
    Singh, Naveena
    Woolas, Robert
    Sharma, Aarti
    Williamson, Karin
    Mould, Tim
    Fallowfield, Lesley
    Campbell, Stuart
    Skates, Steven J.
    McGuire, Alistair
    Parmar, Mahesh
    Jacobs, Ian
    Menon, Usha
    GYNECOLOGIC ONCOLOGY, 2023, 179 : 123 - 130
  • [48] Exercise following breast cancer: exploratory survival analyses of two randomised, controlled trials
    Hayes, S. C.
    Steele, M. L.
    Spence, R. R.
    Gordon, L.
    Battistutta, D.
    Bashford, J.
    Pyke, C.
    Saunders, C.
    Eakin, E.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (02) : 505 - 514
  • [49] Exercise following breast cancer: exploratory survival analyses of two randomised, controlled trials
    S. C. Hayes
    M. L. Steele
    R. R. Spence
    L. Gordon
    D. Battistutta
    J. Bashford
    C. Pyke
    C. Saunders
    E. Eakin
    Breast Cancer Research and Treatment, 2018, 167 : 505 - 514
  • [50] Lung Cancer and Self-Management Interventions: A Systematic Review of Randomised Controlled Trials
    Rowntree, Rachel Anne
    Hosseinzadeh, Hassan
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (01)
12345